These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6739154)

  • 1. [Acute experimental pyelonephritis. Treatment with tobramycin. Influence of the rhythm of administration on efficacy and renal tolerability].
    Herscovici L; Lemeland JF; Dalion J; Olier B; Fillastre JP
    Pathol Biol (Paris); 1984 May; 32(5):450-4. PubMed ID: 6739154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of once daily versus intermittent dosing of tobramycin in rabbits with acute pyelonephritis.
    Herscovici L; Grise G; Thauvin C; Lemeland JF; Fillastre JP
    Scand J Infect Dis; 1988; 20(2):205-12. PubMed ID: 2899906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the efficacy of a single daily injection versus fractionated injections of ceftriaxone in the treatment of acute experimental pyelonephritis].
    Herscovici L; Grise G; Thauvin C; Fillastre JP; Lemeland JF
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):853-6. PubMed ID: 3309828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of experimental Escherichia coli pyelonephritis in rat by ciprofloxacin in comparison with tobramycin.
    Lecomte F; Thauvin-Eliopoulos C; Le Boete I; Grise G; Lemeland JF
    Scand J Infect Dis; 1990; 22(1):75-8. PubMed ID: 2181632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development?
    Burkhardt O; Lehmann C; Madabushi R; Kumar V; Derendorf H; Welte T
    J Antimicrob Chemother; 2006 Oct; 58(4):822-9. PubMed ID: 16885180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bacteriologic, histologic and functional studies of the kidney in 5 days' therapy of experimental E. coli pyelonephritis with gentamycin. Comparison with 9 days' therapy].
    Hagemann I; Briedigkeit H; Strangfeld D; Ditscherlein G; Schürer M; Pietsch R; Kruse I; Camu A; Blank W
    Z Urol Nephrol; 1985 Nov; 78(11):625-31. PubMed ID: 3913218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of dosage regimen on experimental tobramycin nephrotoxicity. A biochemical approach.
    Olier B; Viotte G; Morin JP; Fillastre JP
    Chemotherapy; 1983; 29(6):385-94. PubMed ID: 6653171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective, randomized, controlled study comparing two dosing regimens of gentamicin/oral ciprofloxacin switch therapy for acute pyelonephritis.
    Bailey RR; Begg EJ; Smith AH; Robson RA; Lynn KL; Chambers ST; Barclay ML; Hornibrook J
    Clin Nephrol; 1996 Sep; 46(3):183-6. PubMed ID: 8879853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of the combination of cephalexin with tobramycin on experimental pyelonephritis (author's transl)].
    Hatala M; Morávek J; Liska M; Modr Z; Prát V
    Cas Lek Cesk; 1976 May; 115(20-21):619-22. PubMed ID: 1277247
    [No Abstract]   [Full Text] [Related]  

  • 11. Cefamandole alone and combined with gentamicin or tobramycin in the treatment of acute pyelonephritis.
    Gentry LO; Wood BA; Martin MD; Smythe J
    Scand J Infect Dis Suppl; 1980; suppl 25():96-100. PubMed ID: 7010544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aztreonam versus tobramycin in acute pyelonephritis. A comparative study].
    Gallego J; Jiménez Cruz JF; Gobernado M; Llopis B; Vidal J; Server G; Ruiz JL; David Vera C
    Arch Esp Urol; 1989 Mar; 42(2):116-9. PubMed ID: 2660754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics/pharmacodynamics of levofloxacin 750 mg once daily in young women with acute uncomplicated pyelonephritis.
    Nicolle L; Duckworth H; Sitar D; Bryski L; Harding G; Zhanel G
    Int J Antimicrob Agents; 2008 Mar; 31(3):287-9. PubMed ID: 18155885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic modelling of a once-daily dosing regimen for intravenous tobramycin in paediatric cystic fibrosis patients.
    Lam W; Tjon J; Seto W; Dekker A; Wong C; Atenafu E; Bitnun A; Waters V; Yau Y; Solomon M; Ratjen F
    J Antimicrob Chemother; 2007 Jun; 59(6):1135-40. PubMed ID: 17446242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the pharmacokinetics of tobramycin administered in a single daily dose or in 3 doses in cystic fibrosis].
    Canis F; Trivier D; Vic P; Ategbo S; Turck D; Husson MO
    Pathol Biol (Paris); 1998 Jun; 46(6):449-51. PubMed ID: 9769880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised dosage study of ceftazidime with single daily tobramycin for the empirical management of febrile neutropenia in patients with hematological diseases.
    Gibson J; Johnson L; Snowdon L; Joshua D; Young G; MacLeod C; Iland H; Vincent P; Kronenberg H
    Int J Hematol; 1994 Aug; 60(2):119-27. PubMed ID: 7948961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clarithromycin is an effective immunomodulator in experimental pyelonephritis caused by pan-resistant Klebsiella pneumoniae.
    Giamarellos-Bourboulis EJ; Tziortzioti V; Koutoukas P; Baziaka F; Raftogiannis M; Antonopoulou A; Adamis T; Sabracos L; Giamarellou H
    J Antimicrob Chemother; 2006 May; 57(5):937-44. PubMed ID: 16549515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of melatonin on suppression of renal scarring in experimental model of pyelonephritis.
    Imamoğlu M; Cay A; Cobanoglu U; Bahat E; Karahan C; Tosun I; Sarihan H
    Urology; 2006 Jun; 67(6):1315-9. PubMed ID: 16697444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute CdMT injection is not a good model to study chronic Cd nephropathy: comparison of chronic CdCl2 and CdMT exposure with acute CdMT injection in rats.
    Liu J; Habeebu SS; Liu Y; Klaassen CD
    Toxicol Appl Pharmacol; 1998 Nov; 153(1):48-58. PubMed ID: 9875299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic profile of once daily intravenous tobramycin in children with cystic fibrosis.
    Massie J; Cranswick N
    J Paediatr Child Health; 2006 Oct; 42(10):601-5. PubMed ID: 16972966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.